AR and urinary bladder carcinoma: Although the interaction of PPARG with AR in bladder cancer remains uninvestigated, evidence suggests that PPARG affected bladder cancer development and progression by regulating metastasis, apoptosis, proliferation and reactive oxygen species (ROS) and lipid metabolism.